Procter & Gamble’s (PG) “Outperform” Rating Reaffirmed at Royal Bank Of Canada

Procter & Gamble (NYSE:PG)‘s stock had its “outperform” rating restated by Royal Bank Of Canada in a research note issued on Tuesday, Benzinga reports. They currently have a $166.00 price target on the stock. Royal Bank Of Canada’s price target points to a potential upside of 4.23% from the company’s previous close.

Several other research analysts have also issued reports on the company. TD Cowen reissued a “hold” rating and issued a $150.00 target price on shares of Procter & Gamble in a research report on Wednesday, September 30th. Bank of America decreased their target price on Procter & Gamble from $170.00 to $166.00 and set a “buy” rating for the company in a research report on Friday, July 10th. Jefferies Financial Group raised their price objective on Procter & Gamble from $177.00 to $179.00 and gave the company a “buy” rating in a research report on Friday, June 26th. Argus cut Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Friday, August 7th. Finally, Barclays increased their target price on Procter & Gamble from $146.00 to $152.00 and gave the stock an “equal weight” rating in a research note on Tuesday, July 21st. Fourteen analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $162.20.

Procter & Gamble Stock Up 1.0%

Shares of NYSE PG opened at $159.27 on Tuesday. The company has a current ratio of 0.68, a quick ratio of 0.47 and a debt-to-equity ratio of 0.43. Procter & Gamble has a 12 month low of $137.62 and a 12 month high of $167.25. The firm has a market capitalization of $369.92 billion, a PE ratio of 24.04, a price-to-earnings-growth ratio of 3.96 and a beta of 0.39. The firm has a fifty day simple moving average of $147.11 and a two-hundred day simple moving average of $146.62.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Wednesday, July 29th. The company reported $1.43 EPS for the quarter, topping the consensus estimate of $1.41 by $0.02. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.36%. The business had revenue of $21.20 billion during the quarter, compared to analyst estimates of $21.38 billion. During the same period in the prior year, the business earned $1.48 EPS. The company’s revenue for the quarter was up 1.5% on a year-over-year basis. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. Equities analysts expect that Procter & Gamble will post 6.98 earnings per share for the current year.

Insider Buying and Selling

In related news, CAO Matthew Janzaruk sold 359 shares of the company’s stock in a transaction on Monday, August 24th. The stock was sold at an average price of $145.24, for a total transaction of $52,141.16. Following the completion of the sale, the chief accounting officer owned 1,271 shares in the company, valued at approximately $184,600.04. This represents a 22.02% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Paul Gama sold 2,225 shares of the firm’s stock in a transaction dated Monday, October 5th. The stock was sold at an average price of $145.34, for a total value of $323,381.50. Following the completion of the transaction, the chief executive officer directly owned 51,124 shares in the company, valued at $7,430,362.16. The trade was a 4.17% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 15,135 shares of company stock valued at $2,189,970 over the last ninety days. 0.23% of the stock is owned by insiders.

Institutional Trading of Procter & Gamble

Several large investors have recently added to or reduced their stakes in PG. Net Worth Advisory Group grew its position in Procter & Gamble by 13.2% during the 3rd quarter. Net Worth Advisory Group now owns 6,019 shares of the company’s stock worth $866,000 after acquiring an additional 702 shares during the last quarter. Boyd Wealth Management LLC raised its position in Procter & Gamble by 12.7% in the 3rd quarter. Boyd Wealth Management LLC now owns 4,146 shares of the company’s stock valued at $602,000 after purchasing an additional 468 shares during the last quarter. Lakeside Advisors INC. boosted its stake in Procter & Gamble by 2.4% in the third quarter. Lakeside Advisors INC. now owns 38,587 shares of the company’s stock worth $5,606,000 after purchasing an additional 905 shares in the last quarter. Focused Alpha LLC acquired a new position in Procter & Gamble in the third quarter worth $224,000. Finally, Sumitomo Mitsui DS Asset Management Company Ltd grew its holdings in shares of Procter & Gamble by 1.4% during the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 593,845 shares of the company’s stock worth $86,274,000 after purchasing an additional 8,378 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors.

Trending Headlines about Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Dividend reliability remains a major attraction. Procter & Gamble is highlighted as a “Dividend King” with roughly seven decades of consecutive payout increases. Its income consistency and relatively low-beta business model may appeal to investors seeking stability amid interest-rate and market volatility. Rising Income Over Big Yields: 4 Dividend Kings That Have Raised Payouts for 70 Years Straight
• Positive Sentiment: Innovation efforts could revive organic sales growth. New products, AI-enabled capabilities, productivity initiatives and efforts to strengthen brand market share are being viewed as potential longer-term catalysts. Procter & Gamble’s Innovation Push: Catalyst for Long-Term Growth?
• Positive Sentiment: Head & Shoulders is receiving a targeted product refresh. The new Scalp Care Collection uses clinically tested formulas aimed at dryness, oiliness and sensitivity, potentially improving brand relevance and supporting premium, science-led growth. Why Is Procter & Gamble Refreshing Its Scalp Care Playbook Now?
• Neutral Sentiment: Fiscal first-quarter results are the immediate catalyst. Analysts expect PG to report before the market opens on October 22, with attention on organic sales, volumes, pricing, margins and management’s outlook. The company’s prior quarter showed modest revenue growth and an EPS beat, but revenue fell short of estimates. Procter & Gamble Reports Q1 Earnings on October 22
• Negative Sentiment: Pricing remains a key risk. The earnings preview frames the central tension as a possible recovery in sales volumes versus pricing headwinds. If consumers resist higher prices or volumes remain weak, revenue and organic-growth expectations could come under pressure. Procter & Gamble Earnings Preview: Volume Recovery vs. Pricing Headwind

About Procter & Gamble

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.